Christopher Fuglesang
Founder at Boxer Capital LLC
Network origin in Christopher Fuglesang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 11 | |
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA.
8
| Extinct | Pharmaceuticals: Major | 8 |
| Subsidiary | Pharmaceuticals: Major | 8 | |
Boxer Capital LLC
 Boxer Capital LLC Investment ManagersFinance Boxer Capital LLC (Boxer Capital) is a venture capital subsidiary of Tavistock Group, Inc. founded in 2005 by Chris Fuglesang and Aaron I. Davis. The firm is headquartered in San Diego, California.
8
| Subsidiary | Investment Managers | 8 |
Tavistock Life Sciences Co.
 Tavistock Life Sciences Co. Investment ManagersFinance Tavistock Life Sciences Co (Tavistock Life Sciences Co.) is a venture capital firm founded in 2002. The firm is headquartered in San Diego, California.
7
| Subsidiary | Investment Managers | 7 |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA.
7
| Holding Company | Biotechnology | 7 |
Eidogen-Sertanty, Inc.
 Eidogen-Sertanty, Inc. Miscellaneous Commercial ServicesCommercial Services Eidogen-Sertanty, Inc. provides drug discovery services. Eidogen-Sertanty's nutraceutical products embody years of research and are directed towards proactive health and wellness. It specializes in chemical- and bio-informatics, target and ligand SAR databases, in silico drug discovery, mobile and cloud computing. The company was founded by Steven Muskal in 2003 and is headquartered in Oceanside, CA.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
CiVi Biopharma, Inc.
 CiVi Biopharma, Inc. Pharmaceuticals: MajorHealth Technology CiVi Biopharma, Inc. engages in the research and development of activities focusing on creating novel therapies against cardiovascular and metabolic diseases. The company was founded by Henrik Rum in 2016 and is headquartered in Wilmington, DE.
5
| Holding Company | Pharmaceuticals: Major | 5 |
CiVi Biopharma Holdings, Inc.
 CiVi Biopharma Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services CiVi Biopharma Holdings, Inc. operates as a clinical stage research and development biotechnology company. It create novel cardiovascular and metabolic therapies that have meaningful value to patients. The company is headquartered in Bryn Mawr, PA.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
MVA Investors LLC
 MVA Investors LLC Financial ConglomeratesFinance Part of Tavistock Group, Inc., MVA Investors LLC is a company that provides investment services. The company is based in San Diego, CA. The CEO of the company is Aaron I. Davis.
1
| Subsidiary | Financial Conglomerates | 1 |
Tavistock Life Sciences Co. (Investment Management)
 Tavistock Life Sciences Co. (Investment Management) Investment ManagersFinance Tavistock Life Sciences Co. is an investment manager and venture capital investment firm headquartered in San Diego, California. The firm is a subsidiary of the Tavistock Group, Inc., an international private investment organization comprised of a family office, trading operation, and a portfolio of public investments and private companies. Tavistock Life Sciences provides portfolio management services to individual and institutional clients.
1
| Operating Division | Investment Managers | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher Fuglesang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Pandion Operations, Inc.
 Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Pandion Operations, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Graduate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Tavistock Group, Inc.
 Tavistock Group, Inc. Financial ConglomeratesFinance Tavistock Group, Inc. provides investment services. Its seeks to invest in real estate, hotels, restaurants, healthcare, energy, life sciences, sports and sports ventures. The firm primarily invests in Western Europe, Eastern Europe, United States, South America, Australia, and Caribbean. It also seeks to invest through personal capital. Tavistock Group was founded by Joseph Lewis and is headquartered in Nassau, Bahamas. | Financial Conglomerates | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| Emory University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Director/Board Member Founder Chairman | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Gotham Therapeutics Corp.
 Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Virginia | College/University | Graduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Graduate Degree Doctorate Degree | |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Investment Managers | Private Equity Investor Private Equity Investor | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Doctorate Degree | |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Rochester Christian University | College/University | Doctorate Degree Doctorate Degree | |
| VISTERRA INC | Pharmaceuticals: Major | Director/Board Member Founder | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Doctorate Degree Undergraduate Degree | |
| ALLAKOS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Zephyr Sciences, Inc. | Chief Tech/Sci/R&D Officer Chief Executive Officer | ||
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
UBS Securities LLC
 UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Analyst-Equity Corporate Officer/Principal | |
| Baylor College of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| VENTYX BIOSCIENCES, INC. | Biotechnology | Chairman President | |
Good Therapeutics, Inc.
 Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Good Therapeutics, Inc. operates as a biotechnology company. It develops "context-dependent" protein drugs that sense biomarkers and respond with a therapeutic activity. The company was founded by John Mulligan in 2016 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Packaged Software | Director/Board Member Director/Board Member | |
Bonum Therapeutics, Inc.
 Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bonum Therapeutics, Inc. is a privately held American company that focuses on generating a new class of therapeutics based on a proven technology platform. Bonum Therapeutics is based in an undisclosed location and was founded in 2022 by the Good Therapeutics team. The company's technology utilizes principles of allosteric regulation to create highly active and less toxic medicines, which can be applied to a wide range of therapeutic areas, including oncology, autoimmunity, metabolic disorders, and pain management. The company's molecules combine a sensor component directed against a specific biological marker and a therapeutic component. The company is backed by a group of leading venture investors, including Codon Capital, Roche Venture Fund, RiverVest Venture Partners, 3x5 Partners, Digitalis Ventures, and Vivo Capital. The company was founded by John Mulligan, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Investment Managers | Private Equity Investor Private Equity Investor | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Consultant / Advisor Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Cerus Advisors DMCC
 Cerus Advisors DMCC Investment ManagersFinance Cerus Advisors DMCC (Cerus) is a private equity firm founded in 2015. The firm is headquartered in Dubai with additional offices in UAE and in La Jolla, California, United States. | Investment Managers | Chairman Private Equity Investor | |
| Vandel Group LLC | Chief Executive Officer Corporate Officer/Principal |
Statistics
International
| United States | 48 |
| United Kingdom | 2 |
| Bahamas | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 18 |
| Finance | 8 |
| Commercial Services | 6 |
| Technology Services | 2 |
Operational
| Director/Board Member | 322 |
| Corporate Officer/Principal | 156 |
| Independent Dir/Board Member | 80 |
| Founder | 58 |
| Chief Executive Officer | 56 |
Most connected contacts
| Insiders | |
|---|---|
| Kleanthis Xanthopoulos | 29 |
| Alan Crane | 29 |
| Steven Holtzman | 28 |
| Carole Nüchterlein | 27 |
| Roy Thiele-Sardiña | 26 |
| Peter Kiener | 25 |
| Marios Fotiadis | 25 |
| John McKearn | 25 |
| Fan Yu | 25 |
| Paul Grint | 22 |
| Carlo Rizzuto | 22 |
| Katina Dorton | 22 |
| Peter G. Schultz | 21 |
| Eric Bjerkholt | 21 |
| Sheila Gujrathi | 20 |
- Stock Market
- Insiders
- Christopher Fuglesang
- Company connections
